marijuana stocks news

iMD Companies Inc., to Give Upgraded Guidance on Revenues for 2017 and Offers Free Shipping on all Nutra Pro Energy Bars

Feedback and sales of the Nutra Pro Bar have been very positive, as the company has received many orders after two weeks. The company plans on launching its second Nutra Pro Bar an “Almond Chocolate Butter Bar” next and will announce when it is available for sale.

The company also announced that it plans to give guidance on its upgraded full year revenue projections for 2017. The company received a 60-million-dollar purchase order for 100,000 Metric Tons of Manganese Chrome Powder this month, and revenues have increased dramatically. The company feels that its share value is way undervalued based on its revenue and profit projections for 2017. Because of this the company will give full guidance on the outlook of the company for 2017 once it has received its first quarter financial numbers.

Richard Wilson CEO of iMD stated, “We want to give our shareholders a better picture of where the company is headed based on the revenue and profit projections.  We feel that our share value is undervalued. We want to give the public a better understanding of why our goal is to become a NASDAQ Small Cap company.”

About iMD Companies, Inc. www.imdcompaniesinc.com

iMD Companies, Inc., (ICBU) is a Florida corporation, engaged in the manufacturing and distribution in the hydroponics industries and asset accumulations of revenue producing companies. The company is positioned to be a holding company for acquisitions in the medical, mining and hydroponics industries. Acquisitions in those areas are R-Quest Hydroponics from Anything Technologies Media (EXMT). The company and the principals of the management team have extensive backgrounds in finance, manufacturing, marketing and distribution. ICBU’s goal is to create and increase shareholder value by tactically growing our core business while strategically seeking to acquire new business and create other business alliances, which generate increased revenues and earnings.

About KRSNA Minerals:

KRSNA MINERALS currently has contracts with the Chinese government to supply manganese and Iron ore to China. The recoverable asset values are in excess of 700 million dollars for the total claims owned by KRSNA MINERALS. The Current Claims mined produced revenues in excess of 30 million dollars in 2016 KRSNA MINERALS plans to dramatically increase the number of claims being mined in 2017 to increase revenues exponentially for the company. KRSNA MINERALS is now a wholly owned subsidiary of ICBU and all financials of KRSNA MINERALS will be represented into ICBU financials statements.

Safe Harbor Statement:
Certain statements made in this press release constitute forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. Words such as “expects,” “anticipates,” “plans,”  “scheduled,” “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors. All forward-looking statements speak only as of the date of this press release and the company does not undertake any obligation to update or publicly release any revisions to forward-looking statements


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Cronos Group Inc. (CGC) Reports 2021 Fourth Quarter and Full-Year Results

Cronos Group Reports 2021 Fourth Quarter and Full-Year Results Cronos Group Inc.…

Cara Therapeutics, Inc. (CARA) Announces Difelikefalin (KORSUVA®) Injection New Drug

Cara Therapeutics Announces Difelikefalin (KORSUVA®) Injection New Drug Application Has Been Submitted…

$IMLFF Strengthens Board With Appointment of Experienced Biotech Executive

InMed Strengthens Board With Appointment of Experienced Biotech Executive Adam Cutler InMed…